Thermon Group Holdings, Inc. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that Thermon Group Holdings, Inc. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2022 | Jun 30, 2021 | $73.32M | May 26, 2022 |
| FY2022 | Mar 31, 2021 | $276.18M | May 26, 2022 |
| FY2020 | Mar 31, 2020 | $88.37M | Jun 1, 2020 |
| FY2020 | Dec 31, 2019 | $100.47M | Jun 1, 2020 |
| FY2020 | Sep 30, 2019 | $102.94M | Jun 1, 2020 |
| FY2020 | Jun 30, 2019 | $91.71M | Jun 1, 2020 |
| FY2020 | Mar 31, 2019 | $114.23M | Jun 1, 2020 |
| FY2020 | Dec 31, 2018 | $119.36M | Jun 1, 2020 |
| FY2020 | Sep 30, 2018 | $90.15M | Jun 1, 2020 |
| FY2020 | Jun 30, 2018 | $88.90M | Jun 1, 2020 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | $498.21M | May 22, 2025 |
| FY2025 | Mar 31, 2024 | $494.63M | May 22, 2025 |
| FY2025 | Mar 31, 2023 | $440.59M | May 22, 2025 |
| FY2024 | Mar 31, 2022 | $355.67M | May 29, 2024 |
| FY2023 | Mar 31, 2021 | $276.18M | May 25, 2023 |
| FY2022 | Mar 31, 2020 | $383.49M | May 26, 2022 |
| FY2021 | Mar 31, 2019 | $412.64M | May 27, 2021 |
| FY2020 | Mar 31, 2018 | $308.61M | Jun 1, 2020 |
| FY2019 | Mar 31, 2017 | $264.13M | Jun 12, 2019 |
Revenue (Net Sales)
Net sales revenue — gross revenue less returns, allowances, and discounts. Used by many manufacturers and retailers as the primary top-line figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2018 | Mar 31, 2018 | $308.61M | Jun 8, 2018 |
| FY2018 | Mar 31, 2017 | $264.13M | Jun 8, 2018 |
| FY2018 | Mar 31, 2016 | $281.93M | Jun 8, 2018 |
| FY2016 | Mar 31, 2015 | $74.26M | May 31, 2016 |
| FY2015 | Mar 31, 2014 | $67.48M | Jun 1, 2015 |
| FY2016 | Dec 31, 2013 | $87.62M | May 31, 2016 |
| FY2016 | Sep 30, 2013 | $79.03M | May 31, 2016 |
| FY2016 | Jun 30, 2013 | $67.67M | May 31, 2016 |
| FY2013 | Mar 31, 2013 | $71.67M | May 30, 2014 |
| FY2013 | Dec 31, 2012 | $76.83M | May 30, 2014 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | $222.90M | May 22, 2025 |
| FY2025 | Mar 31, 2024 | $211.56M | May 22, 2025 |
| FY2025 | Mar 31, 2023 | $185.13M | May 22, 2025 |
| FY2024 | Mar 31, 2022 | $140.12M | May 29, 2024 |
| FY2022 | Jun 30, 2021 | $26.86M | May 26, 2022 |
| FY2023 | Mar 31, 2021 | $116.87M | May 25, 2023 |
| FY2020 | Mar 31, 2020 | $35.58M | Jun 1, 2020 |
| FY2020 | Dec 31, 2019 | $43.48M | Jun 1, 2020 |
| FY2020 | Sep 30, 2019 | $45.43M | Jun 1, 2020 |
| FY2020 | Jun 30, 2019 | $37.14M | Jun 1, 2020 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | $53.52M | May 22, 2025 |
| FY2025 | Mar 31, 2024 | $51.59M | May 22, 2025 |
| FY2025 | Mar 31, 2023 | $33.67M | May 22, 2025 |
| FY2024 | Mar 31, 2022 | $20.09M | May 29, 2024 |
| FY2022 | Jun 30, 2021 | ($1.05M) | May 26, 2022 |
| FY2023 | Mar 31, 2021 | $877.0K | May 25, 2023 |
| FY2020 | Mar 31, 2020 | ($2.97M) | Jun 1, 2020 |
| FY2020 | Dec 31, 2019 | $6.52M | Jun 1, 2020 |
| FY2020 | Sep 30, 2019 | $6.91M | Jun 1, 2020 |
| FY2020 | Jun 30, 2019 | $1.47M | Jun 1, 2020 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | $79.76M | May 22, 2025 |
| FY2025 | Mar 31, 2024 | $75.37M | May 22, 2025 |
| FY2025 | Mar 31, 2023 | $55.19M | May 22, 2025 |
| FY2024 | Mar 31, 2022 | $38.41M | May 29, 2024 |
| FY2023 | Mar 31, 2021 | $7.41M | May 25, 2023 |
| FY2020 | Mar 31, 2020 | $2.37M | Jun 1, 2020 |
| FY2020 | Dec 31, 2019 | $12.47M | Jun 1, 2020 |
| FY2020 | Sep 30, 2019 | $12.84M | Jun 1, 2020 |
| FY2020 | Jun 30, 2019 | $4.99M | Jun 1, 2020 |
| FY2020 | Mar 31, 2019 | $13.71M | Jun 1, 2020 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | $9.41M | May 22, 2025 |
| FY2025 | Mar 31, 2024 | $9.80M | May 22, 2025 |
| FY2025 | Mar 31, 2023 | $10.57M | May 22, 2025 |
| FY2024 | Mar 31, 2022 | $6.44M | May 29, 2024 |
| FY2023 | Mar 31, 2021 | $7.47M | May 25, 2023 |
| FY2022 | Mar 31, 2020 | $8.38M | May 26, 2022 |
| FY2021 | Mar 31, 2019 | $6.29M | May 27, 2021 |
| FY2020 | Mar 31, 2018 | $5.24M | Jun 1, 2020 |
| FY2019 | Mar 31, 2017 | $3.50M | Jun 12, 2019 |
| FY2018 | Mar 31, 2016 | $3.34M | Jun 8, 2018 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | $129.31M | May 22, 2025 |
| FY2025 | Mar 31, 2024 | $123.82M | May 22, 2025 |
| FY2025 | Mar 31, 2023 | $117.00M | May 22, 2025 |
| FY2024 | Mar 31, 2022 | $93.05M | May 29, 2024 |
| FY2023 | Mar 31, 2021 | $89.83M | May 25, 2023 |
| FY2022 | Mar 31, 2020 | $111.59M | May 26, 2022 |
| FY2021 | Mar 31, 2019 | $106.66M | May 27, 2021 |
| FY2020 | Mar 31, 2018 | $94.62M | Jun 1, 2020 |
| FY2019 | Mar 31, 2017 | $77.72M | Jun 12, 2019 |
| FY2018 | Mar 31, 2016 | $80.73M | Jun 8, 2018 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | $63.12M | May 22, 2025 |
| FY2025 | Mar 31, 2024 | $65.96M | May 22, 2025 |
| FY2025 | Mar 31, 2023 | $57.71M | May 22, 2025 |
| FY2024 | Mar 31, 2022 | $28.75M | May 29, 2024 |
| FY2023 | Mar 31, 2021 | $30.29M | May 25, 2023 |
| FY2022 | Mar 31, 2020 | $70.73M | May 26, 2022 |
| FY2021 | Mar 31, 2019 | $23.23M | May 27, 2021 |
| FY2020 | Mar 31, 2018 | $22.91M | Jun 1, 2020 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | $10.25M | May 22, 2025 |
| FY2025 | Mar 31, 2024 | $11.02M | May 22, 2025 |
| FY2025 | Mar 31, 2023 | $9.45M | May 22, 2025 |
| FY2024 | Mar 31, 2022 | $5.22M | May 29, 2024 |
| FY2023 | Mar 31, 2021 | $8.13M | May 25, 2023 |
| FY2022 | Mar 31, 2020 | $10.86M | May 26, 2022 |
| FY2021 | Mar 31, 2019 | $12.04M | May 27, 2021 |
| FY2020 | Mar 31, 2018 | $10.01M | Jun 1, 2020 |
| FY2019 | Mar 31, 2017 | $8.37M | Jun 12, 2019 |
| FY2018 | Mar 31, 2016 | $12.58M | Jun 8, 2018 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | $755.45M | May 22, 2025 |
| FY2025 | Mar 31, 2024 | $767.74M | May 22, 2025 |
| FY2024 | Mar 31, 2023 | $649.63M | May 29, 2024 |
| FY2023 | Mar 31, 2022 | $636.67M | May 25, 2023 |
| FY2022 | Mar 31, 2021 | $617.88M | May 26, 2022 |
| FY2021 | Mar 31, 2020 | $620.91M | May 27, 2021 |
| FY2020 | Mar 31, 2019 | $655.76M | Jun 1, 2020 |
| FY2019 | Mar 31, 2018 | $662.48M | Jun 12, 2019 |
| FY2018 | Mar 31, 2017 | $454.08M | Jun 8, 2018 |
| FY2017 | Mar 31, 2016 | $468.68M | May 30, 2017 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | $260.14M | May 22, 2025 |
| FY2025 | Mar 31, 2024 | $292.85M | May 22, 2025 |
| FY2024 | Mar 31, 2023 | $230.64M | May 29, 2024 |
| FY2023 | Mar 31, 2022 | $237.47M | May 25, 2023 |
| FY2022 | Mar 31, 2021 | $239.01M | May 26, 2022 |
| FY2021 | Mar 31, 2020 | $274.47M | May 27, 2021 |
| FY2020 | Mar 31, 2019 | $306.81M | Jun 1, 2020 |
| FY2019 | Mar 31, 2018 | $321.62M | Jun 12, 2019 |
| FY2018 | Mar 31, 2017 | $141.58M | Jun 8, 2018 |
| FY2017 | Mar 31, 2016 | $169.98M | May 30, 2017 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | $495.32M | May 22, 2025 |
| FY2025 | Mar 31, 2024 | $474.89M | May 22, 2025 |
| FY2025 | Mar 31, 2023 | $418.99M | May 22, 2025 |
| FY2025 | Mar 31, 2022 | $399.20M | May 22, 2025 |
| FY2024 | Mar 31, 2021 | $378.87M | May 29, 2024 |
| FY2020 | Mar 31, 2020 | $346.44M | Jun 1, 2020 |
| FY2020 | Mar 31, 2019 | $344.75M | Jun 1, 2020 |
| FY2019 | Mar 31, 2018 | $334.93M | Jun 12, 2019 |
| FY2018 | Mar 31, 2017 | $307.88M | Jun 8, 2018 |
| FY2017 | Mar 31, 2016 | $294.42M | May 30, 2017 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | $264.33M | May 22, 2025 |
| FY2025 | Mar 31, 2024 | $270.79M | May 22, 2025 |
| FY2025 | Mar 31, 2023 | $219.61M | May 22, 2025 |
| FY2024 | Mar 31, 2022 | $212.75M | May 29, 2024 |
| FY2022 | Mar 31, 2021 | $213.04M | May 26, 2022 |
| FY2021 | Mar 31, 2020 | $197.98M | May 27, 2021 |
| FY2020 | Mar 31, 2019 | $205.00M | Jun 1, 2020 |
| FY2019 | Mar 31, 2018 | $210.57M | Jun 12, 2019 |
| FY2018 | Mar 31, 2017 | $122.52M | Jun 8, 2018 |
| FY2017 | Mar 31, 2016 | $121.51M | May 30, 2017 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | $342.30M | May 22, 2025 |
| FY2025 | Mar 31, 2024 | $288.78M | May 22, 2025 |
| FY2024 | Mar 31, 2023 | $237.20M | May 29, 2024 |
| FY2023 | Mar 31, 2022 | $203.53M | May 25, 2023 |
| FY2022 | Mar 31, 2021 | $183.44M | May 26, 2022 |
| FY2021 | Mar 31, 2020 | $182.56M | May 27, 2021 |
| FY2020 | Mar 31, 2019 | $170.62M | Jun 1, 2020 |
| FY2019 | Mar 31, 2018 | $148.81M | Jun 12, 2019 |
| FY2018 | Mar 31, 2017 | $136.90M | Jun 8, 2018 |
| FY2017 | Mar 31, 2016 | $122.26M | May 30, 2017 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | $39.54M | May 22, 2025 |
| FY2025 | Mar 31, 2024 | $48.63M | May 22, 2025 |
| FY2024 | Mar 31, 2023 | $35.64M | May 29, 2024 |
| FY2023 | Mar 31, 2022 | $41.45M | May 25, 2023 |
| FY2022 | Mar 31, 2021 | $40.12M | May 26, 2022 |
| FY2021 | Mar 31, 2020 | $43.24M | May 27, 2021 |
| FY2020 | Mar 31, 2019 | $31.40M | Jun 1, 2020 |
| FY2019 | Mar 31, 2018 | $33.88M | Jun 12, 2019 |
| FY2018 | Mar 31, 2017 | $42.84M | Jun 8, 2018 |
| FY2018 | Mar 31, 2016 | $84.57M | Jun 8, 2018 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | $138.88M | May 22, 2025 |
| FY2024 | Mar 31, 2024 | $167.50M | May 29, 2024 |
| FY2023 | Mar 31, 2023 | $98.36M | May 25, 2023 |
| FY2022 | Mar 31, 2022 | $129.00M | May 26, 2022 |
| FY2021 | Mar 31, 2021 | $148.50M | May 27, 2021 |
| FY2020 | Mar 31, 2020 | $176.00M | Jun 1, 2020 |
| FY2019 | Mar 31, 2019 | $206.50M | Jun 12, 2019 |
| FY2018 | Mar 31, 2018 | $225.00M | Jun 8, 2018 |
| FY2017 | Mar 31, 2017 | $81.00M | May 30, 2017 |
| FY2016 | Mar 31, 2016 | $94.50M | May 31, 2016 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | 1 | May 22, 2025 |
| FY2025 | Mar 31, 2024 | 1 | May 22, 2025 |
| FY2025 | Mar 31, 2023 | 1 | May 22, 2025 |
| FY2024 | Mar 31, 2022 | 0 | May 29, 2024 |
| FY2022 | Jun 30, 2021 | (30) | May 26, 2022 |
| FY2023 | Mar 31, 2021 | 0 | May 25, 2023 |
| FY2020 | Mar 31, 2020 | 0 | Jun 1, 2020 |
| FY2020 | Dec 31, 2019 | 0 | Jun 1, 2020 |
| FY2020 | Sep 30, 2019 | 0 | Jun 1, 2020 |
| FY2020 | Jun 30, 2019 | 0 | Jun 1, 2020 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | 1 | May 22, 2025 |
| FY2025 | Mar 31, 2024 | 1 | May 22, 2025 |
| FY2025 | Mar 31, 2023 | 1 | May 22, 2025 |
| FY2024 | Mar 31, 2022 | 0 | May 29, 2024 |
| FY2022 | Jun 30, 2021 | (30) | May 26, 2022 |
| FY2023 | Mar 31, 2021 | 0 | May 25, 2023 |
| FY2020 | Mar 31, 2020 | 0 | Jun 1, 2020 |
| FY2020 | Dec 31, 2019 | 0 | Jun 1, 2020 |
| FY2020 | Sep 30, 2019 | 0 | Jun 1, 2020 |
| FY2020 | Jun 30, 2019 | 0 | Jun 1, 2020 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | 33.24M | May 22, 2025 |
| FY2025 | Mar 31, 2024 | 33.72M | May 22, 2025 |
| FY2024 | Mar 31, 2023 | 33.51M | May 29, 2024 |
| FY2023 | Mar 31, 2022 | 33.36M | May 25, 2023 |
| FY2022 | Mar 31, 2021 | 33.23M | May 26, 2022 |
| FY2021 | Mar 31, 2020 | 32.92M | May 27, 2021 |
| FY2020 | Mar 31, 2019 | 32.62M | Jun 1, 2020 |
| FY2019 | Mar 31, 2018 | 32.49M | Jun 12, 2019 |
| FY2018 | Mar 31, 2017 | 32.37M | Jun 8, 2018 |
| FY2017 | Mar 31, 2016 | 32.22M | May 30, 2017 |
Dividends Paid
Cash dividends distributed to common shareholders during the period. Shown as a positive value despite being a cash outflow in the SEC filing.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2011 | Mar 31, 2012 | $0 | Jun 8, 2012 |
| FY2011 | Mar 31, 2011 | $0 | Jun 8, 2012 |